Gábor Mikala

5.0k total citations
123 papers, 2.2k citations indexed

About

Gábor Mikala is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Gábor Mikala has authored 123 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 75 papers in Hematology and 26 papers in Oncology. Recurrent topics in Gábor Mikala's work include Multiple Myeloma Research and Treatments (64 papers), Ion channel regulation and function (31 papers) and Cardiac electrophysiology and arrhythmias (25 papers). Gábor Mikala is often cited by papers focused on Multiple Myeloma Research and Treatments (64 papers), Ion channel regulation and function (31 papers) and Cardiac electrophysiology and arrhythmias (25 papers). Gábor Mikala collaborates with scholars based in Hungary, United States and Germany. Gábor Mikala's co-authors include Arnold Schwartz, Gyula Váradi, Atsuko Yatani, Yasuo Mori, Minoru Wakamori, Anthony Bahinski, Udo Klöckner, Ilona Bódi, Shiqi Tang and David Iles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Gábor Mikala

111 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gábor Mikala Hungary 26 1.7k 792 721 486 301 123 2.2k
Stuart J. Mundell United Kingdom 35 1.8k 1.1× 1.1k 1.4× 460 0.6× 611 1.3× 213 0.7× 78 3.0k
Ursula Quitterer Germany 30 2.1k 1.2× 899 1.1× 893 1.2× 177 0.4× 179 0.6× 55 3.3k
Daniel Palmer United States 19 1.4k 0.9× 341 0.4× 359 0.5× 225 0.5× 92 0.3× 27 2.1k
John M. Millholland United States 9 2.1k 1.3× 348 0.4× 1.1k 1.5× 159 0.3× 259 0.9× 15 2.6k
M. Wittner France 24 1.2k 0.7× 292 0.4× 154 0.2× 320 0.7× 220 0.7× 51 2.1k
Alicia Lundby Denmark 23 1.5k 0.9× 328 0.4× 669 0.9× 54 0.1× 226 0.8× 43 2.2k
Fernand Gobeil Canada 31 1.2k 0.7× 521 0.7× 318 0.4× 180 0.4× 201 0.7× 77 2.7k
Barrie Ashby United States 25 819 0.5× 370 0.5× 381 0.5× 426 0.9× 90 0.3× 47 1.9k
Antonio Feliciello Italy 37 2.4k 1.5× 508 0.6× 330 0.5× 93 0.2× 234 0.8× 67 3.5k
Michelle I. Lin United States 27 1.6k 0.9× 362 0.5× 390 0.5× 87 0.2× 268 0.9× 37 2.9k

Countries citing papers authored by Gábor Mikala

Since Specialization
Citations

This map shows the geographic impact of Gábor Mikala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Mikala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Mikala more than expected).

Fields of papers citing papers by Gábor Mikala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gábor Mikala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Mikala. The network helps show where Gábor Mikala may publish in the future.

Co-authorship network of co-authors of Gábor Mikala

This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Mikala. A scholar is included among the top collaborators of Gábor Mikala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Mikala. Gábor Mikala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Várkonyi, Andrea, Hajnalka Andrikovics, Mónika Fekete, et al.. (2024). Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review. Pharmaceuticals. 17(12). 1722–1722.
2.
Pour, Luděk, Ganna Usenko, Gábor Mikala, et al.. (2024). PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24(6). e267–e275.e2. 1 indexed citations
3.
Ungvári, Zoltán, Mónika Fekete, Andrea B. Maier, et al.. (2024). Genomic instability and genetic heterogeneity in aging: insights from clonal hematopoiesis (CHIP), monoclonal gammopathy (MGUS), and monoclonal B-cell lymphocytosis (MBL). GeroScience. 47(1). 703–720. 10 indexed citations
4.
5.
6.
7.
Dimopoulos, Meletios Α., Vânia Hungria, Atanas Radinoff, et al.. (2023). S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3). HemaSphere. 7(S3). e072005a–e072005a. 2 indexed citations
8.
Gézsi, András, Tamás Masszi, Gábor Mikala, et al.. (2022). Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement. Biomedicines. 10(3). 519–519. 1 indexed citations
9.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2022). Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy—Analysis of 130 Eyes of 65 Subjects. Journal of Clinical Medicine. 11(7). 1848–1848. 4 indexed citations
10.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2021). Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects. Journal of Ophthalmology. 2021. 1–8. 2 indexed citations
11.
Garderet, Laurent, Joanna Wasielica‐Poslednik, Markus Munder, et al.. (2021). Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes. Leukemia & lymphoma. 63(4). 984–990. 3 indexed citations
12.
Kaló, Zoltán, István Vályi‐Nagy, Gergely Varga, et al.. (2020). PPM6 EARLY PHASE ECONOMIC EVALUATION OF NEW GENERATION SEQUENCE DIAGNOSTICS IN MULTIPLE MYELOMA. Value in Health. 23. S326–S327. 1 indexed citations
13.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
14.
Moreau, Philippe, Simon J. Harrison, Michèle Cavo, et al.. (2019). Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 1888–1888. 28 indexed citations
15.
Varga, Gergely, Gábor Mikala, László Gopcsa, et al.. (2018). Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature. Journal of Oncology. 2018. 1–7. 28 indexed citations
16.
Varga, Gergely, Gábor Mikala, András Bors, et al.. (2017). The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma. 59(3). 710–716. 1 indexed citations
17.
Basak, Grzegorz, Ozren Jakšić, Zdeněk Kořı́stek, et al.. (2011). Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells. European Journal Of Haematology. 86(6). 488–495. 23 indexed citations
18.
Malard, Florent, Nicolaus Kröger, Ian H Gabriel, et al.. (2011). Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide. Biology of Blood and Marrow Transplantation. 18(2). 314–317. 32 indexed citations
19.
Mori, Yasuo, Gábor Mikala, Gyula Váradi, et al.. (1996). Molecular Pharmacology of Voltage-Dependent Calcium Channels. The Japanese Journal of Pharmacology. 72(2). 83–109. 80 indexed citations
20.
Kobayashi, Tsutomu, Gábor Mikala, & Atsuko Yatani. (1995). A novel enhancing effect of clofilium on transient outward‐type cloned cardiac K+ channel currents. British Journal of Pharmacology. 114(6). 1222–1226. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart J. Mundell Breakdown of academic impact, for papers by Ursula Quitterer Breakdown of academic impact, for papers by Daniel Palmer Breakdown of academic impact, for papers by John M. Millholland Breakdown of academic impact, for papers by M. Wittner Breakdown of academic impact, for papers by Alicia Lundby Breakdown of academic impact, for papers by Fernand Gobeil Breakdown of academic impact, for papers by Barrie Ashby Breakdown of academic impact, for papers by Antonio Feliciello Breakdown of academic impact, for papers by Michelle I. Lin
Rankless by CCL
2026